MORESCO ROSA MARIA

Cerina, V., Pozzi, F., De Bernardi, E., Crivellaro, C., Moresco, R., Ferrarese, C., et al. (2025). Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study. Intervento presentato a: NeuroMI 2025 International Meeting: “Artificial Intelligence for Neuroscience: from basic research to clinical practice“, October 15-17, 2025, Milano, Italia. Dettaglio

Iannone, M., Kravicz, M., Rainone, P., Antoniou, A., Stucchi, S., Valtorta, S., et al. (2025). Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1566257]. Dettaglio

Rizzo, R., Rainone, P., Stefania, R., Belloli, S., Valtorta, S., Coliva, A., et al. (2025). Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP). EJNMMI RADIOPHARMACY AND CHEMISTRY, 10(1) [10.1186/s41181-025-00375-2]. Dettaglio

Alborghetti, L., Vurro, F., Belloli, S., Rainone, P., Valtorta, S., Milani Capialbi, M., et al. (2025). Cerenkov luminescence microscopy: A novel approach for high-resolution radiotracer imaging. ISCIENCE, 28(11) [10.1016/j.isci.2025.113840]. Dettaglio

Pisano, A., Belloli, S., Pignataro, M., Rainone, P., Valtorta, S., Coliva, A., et al. (2025). Peptide-mimetics derived from leucyl-tRNA synthetase are potential agents for the therapy of mt-tRNA related diseases. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1607343]. Dettaglio